PhD defences
-
18 Sept. 2026, 11:00-14:00
Beyond the Randomized Trial: A Network Meta-Analysis of DMARDs for Rheumatoid Arthritis
-
18 Sept. 2026, 13:00-16:00
PhD defence by Jane Hybschmann Sørensen
-
18 Sept. 2026, 13:00-16:00
PhD defence by Henrik Hjul Møller
-
18 Sept. 2026, 14:00-17:00
Meniere’s disease - Epidemiology, Economic and Welfare Consequences, Diagnostic Innovations, and Treatment Strategies
-
21 Sept. 2026, 12:30-15:30
Development and Scalable Production of Inactivated HCV and SARS-CoV-2 Vaccines: From Bioprocess Integration to Immunological Ev
-
21 Sept. 2026, 14:00-17:00
Gastrointestinal hormones after intestinal resection and the therapeutic use of the glucagon-like peptide 2 analog, glepaglutid
-
21 Sept. 2026, 15:45-18:45
Modulating the Muscarinic M1 Receptor to Inhibit Drug Seeking Behaviour: A Promising Target in Cocaine Addiction Treatment
-
22 Sept. 2026, 14:00-17:00
Optimizing refractive outcomes and patient satisfaction in cataract patients
-
23 Sept. 2026, 9:00-12:00
Mechanisms of cardiac pathology in a mouse model of obesity, hypertension and diabetic kidney disease
-
24 Sept. 2026, 14:00-17:00
From Adrenal Insufficiency to Adrenal Incidentalomas: Diagnostic Challenges and Balanced Treatment Strategies
-
24 Sept. 2026, 14:00-17:00
Defining the Rho GTPase Cdc42 as a novel regulator of skeletal muscle adaptations
-
25 Sept. 2026, 10:00-13:00
Preservation of DNA on substrates and implications for horizontal gene transfer
-
25 Sept. 2026, 13:00-16:00
Lung Cancer, Rehabilitation, and Inequality in Everyday Life
-
25 Sept. 2026, 13:00-16:00
Towards a strengthened animal health risk assessment process in Denmark
-
25 Sept. 2026, 13:00-16:00
Uncovering human hypothalamic lineage trajectories using hPSC-derived neural subtype populations
-
25 Sept. 2026, 14:00-17:00
The cost of cure: Severe Toxicity-Free Survival in Childhood Acute Lymphoblastic Leukemia
-
25 Sept. 2026, 14:00-17:00
Expanding the concept of hormones – small non-coding RNAs as endocrine messengers
-
30 Sept. 2026, 12:00-15:00
Functional Mapping of Cortex-Basal Ganglia Circuits in Parkinson’s Disease with and without Levodopa-Induced Dyskinesia
-
30 Sept. 2026, 13:00-16:00
Real-world challenges of immune checkpoint inhibitors: immune-related adverse events and treatment duration
-
30 Sept. 2026, 14:00-17:00
Complexity in polypharmacy - A data-driven study of genetics, drug interactions and patient outcomes
-
2 Oct. 2026, 14:00-17:00
Perioperative Cardiovascular Injury in Colorectal Cancer Surgery - Clinical Outcomes and Molecular Insights
-
5 Oct. 2026, 13:00-16:00
Post-Marketing Safety of Antidiabetic Drugs: From Regulatory Oversight to Active Surveillance in EU Pharmacovigilance
-
5 Oct. 2026, 13:30-16:30
he cellular composition of the skin: A single cell omics study of the skin of healthy humans and patients with allergic contact
-
6 Oct. 2026, 10:00-13:00
Comprehensive plasma proteomic analysis for biomarker discovery in metabolic dysfunction-associated steatotic liver disease
-
7 Oct. 2026, 13:00-16:00
Metabolic Effects of Ruminococcus torques ATCC 27756 Strain and RORDEP1
-
7 Oct. 2026, 14:00-17:00
Coronary Imaging, Physiology, and Residual Risk After Primary PCI for Myocardial Infarction
-
9 Oct. 2026, 13:00-16:00
Super-Resolution Ultrasound Imaging of the Microvasculature – From Rat Kidneys to Human Lymph Nodes
-
15 Oct. 2026, 9:00-12:00
Clinical applications of pharmacokinetic and pharmacodynamic analyses of antibiotics in infective endocarditis
-
23 Oct. 2026, 10:00-13:00
The Role of Actin Regulators on DNA Damage Respons
-
6 Nov. 2026, 13:00-16:00
Investigations of impaired subcutaneous adipose tissue expandability in low birth weight men
-
13 Nov. 2026, 14:00-17:00
Continuous glucose monitoring and insulin analogs during pregnancy and delivery in women with preexisting diabetes
-
16 Nov. 2026, 14:00-17:00
Palmoplantar inflammatory skin diseases – clinical and molecular characterisation
-
16 Nov. 2026, 14:00-17:00
Implementation of Evidence-Based Care to Improve Cardiovascular and Kidney Health - Insights from four nationwide implementatio
-
20 Nov. 2026, 14:00-17:00
Computer-based Cognitive Rehabilitation of Acquired Brain Injuries and Neurological Disorders
-
20 Nov. 2026, 15:00-18:00
Opioids and the Mesopontine Cholinergic Nuclei: Explorations of a new target for combating opioid addiction